Phase II study of single agent oral vinorelbine as a first line treatment for postmenopausal patients with locally recurrent or metastatic breast cancer previously treated with anthracycline or taxanes

被引：0
|
作者：
Elebrashi, M. [1 ]
机构：
[1] Mansoura Univ, Clin Oncol, Dakahlia, Egypt
来源：
EUROPEAN JOURNAL OF CANCER | 2016年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
391
引用
收藏
页码：S113 / S113
页数：1
相关论文
共 50 条
  • [1] Phase II study of oral vinorelbine in combination with capecitabine as second line chemotherapy in metastatic breast cancer patients previously treated with anthracyclines and taxanes
    Alison Jones
    Mary O’Brien
    Harald Sommer
    Elzbieta Nowara
    Anja Welt
    Tadeusz Pienkowski
    Janusz Rolski
    My-Linh Pham
    Kevin Perraud
    Véronique Trillet-Lenoir
    Cancer Chemotherapy and Pharmacology, 2010, 65 : 755 - 763
  • [2] Phase II study of oral vinorelbine in combination with capecitabine as second line chemotherapy in metastatic breast cancer patients previously treated with anthracyclines and taxanes
    Jones, Alison
    O'Brien, Mary
    Sommer, Harald
    Nowara, Elzbieta
    Welt, Anja
    Pienkowski, Tadeusz
    Rolski, Janusz
    Pham, My-Linh
    Perraud, Kevin
    Trillet-Lenoir, Veronique
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 65 (04) : 755 - 763
  • [3] Phase II study of single agent oral vinorelbine as first-line treatment in patients with HER-2 negative metastatic breast cancer
    Maged Mansour
    Cynthia Mourad
    Cancer Chemotherapy and Pharmacology, 2013, 72 : 429 - 435
  • [4] Phase II study of single agent oral vinorelbine as first-line treatment in patients with HER-2 negative metastatic breast cancer
    Mansour, Maged
    Mourad, Cynthia
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 72 (02) : 429 - 435
  • [5] A Phase II trial of the combination of vinorelbine and capecitabine as second-line treatment in metastatic breast cancer previously treated with taxanes and/or anthracyclines
    George Orphanos
    Athanasios Alexopoulos
    Savvoula Malliou
    George Ioannidis
    Alexandros Ardavanis
    Constantinos Kandylis
    John Stavrakakis
    Gerassimos Rigatos
    Journal of Cancer Research and Clinical Oncology, 2010, 136 : 115 - 121
  • [6] A Phase II trial of the combination of vinorelbine and capecitabine as second-line treatment in metastatic breast cancer previously treated with taxanes and/or anthracyclines
    Orphanos, George
    Alexopoulos, Athanasios
    Malliou, Savvoula
    Ioannidis, George
    Ardavanis, Alexandros
    Kandylis, Constantinos
    Stavrakakis, John
    Rigatos, Gerassimos
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2010, 136 (01) : 115 - 121
  • [7] Oral Vinorelbine in Combination With Capecitabine as a First Line Treatment in Patients (pts) With Metastatic Breast Cancer (MBC) Previously Treated With Anthracyclines ± Taxanes - Preliminary Results of a Multicentric Phase II Trial in Egypt
    Kandil, A.
    Hamada, E.
    Moawad, M.
    El Arab, L. Ezz
    Metwalli, H.
    Bathiouny, M.
    Mourad, C.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S351 - S351
  • [8] Phase II study of vinorelbine (NVB) and UFT in patients with metastatic breast cancer (MBC) previously treated with anthracyclines and taxanes.
    Anton, A
    Puertolas, T
    Ramos, M
    Barnadas, A
    Florian, J
    Grande, R
    Ribelles, N
    Lomas, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 64S - 64S
  • [9] A phase I study of an all-oral combination of vinorelbine/capecitabine in patients with metastatic breast cancer previously treated with anthracyclines and/or taxanes
    Kellokumpu-Lehtinen, Pirkko-Liisa
    Sunela, Kaisa
    Lehtinen, Ilari
    Joensuu, Heikki
    Sjostrom-Mattson, Johanna
    CLINICAL BREAST CANCER, 2006, 7 (05) : 401 - 405
  • [10] Late phase II clinical study of vinorelbine monotherapy in advanced or recurrent breast cancer previously treated with anthracyclines and taxanes
    Toi, M
    Saeki, T
    Aogi, K
    Sano, M
    Hatake, K
    Asaga, T
    Tokuda, Y
    Mitsuyama, S
    Kimura, M
    Kobayashi, T
    Tamura, M
    Tabei, T
    Shin, E
    Nishimura, R
    Ohno, S
    Takashima, S
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2005, 35 (06) : 310 - 315
12345